Key Takeaways
Hormone dosing is personalized, but patients with similar profiles may be prescribed the same dose
Dr. Green explained that Winona physicians determine starting doses based on a patient’s age and symptom profile. Doses are then adjusted as needed based on how symptoms respond. Because there are only so many available dose strengths, patients with similar clinical profiles may receive the same dose. He clarified that personalized care means tailoring the treatment regimen to the individual; it doesn't mean that every numerical dose is unique to one person.
Bioidentical hormones are plant-derived and structurally identical to the body's own hormones
The doctors explained that Winona's estrogen, progesterone, and DHEA come from plant sources and are chemically identical to the hormones the body naturally produces. This is what differentiates "bioidentical" hormones from synthetic alternatives, which are derived from other sources and have a different molecular structure.
A family history of breast cancer doesn't automatically rule out HRT
Dr. Brown explained that a family history alone doesn't automatically make a person ineligible for HRT. She clarified by providing examples of higher-risk cases in which a systemic HRT prescription may not be appropriate, such as having a first-degree relative diagnosed with breast cancer who tested positive for a genetic mutation like BRCA. For women with a personal history of breast cancer, closely monitored, in-person menopause care in conjunction with an oncologist is more appropriate than telehealth HRT care.
Vaginal estrogen works differently from systemic HRT
The doctors noted that low-dose vaginal estrogen cream treats tissue atrophy locally, meaning there is minimal systemic absorption into the bloodstream. This is why vaginal estrogen can be used safely alongside systemic HRT or on its own without added progesterone for uterine protection.
There's no universal stop date for HRT
Dr. Green explained that older clinical guidance to use "the lowest dose for the shortest time" has evolved now that we have a broader understanding of HRT's long-term bone and cardiovascular benefits. Many women continue treatment well past 60 as long as HRT was initiated around the time of menopause, effectively manages symptoms, and there's no medical reason to stop.
